Quarterly report pursuant to Section 13 or 15(d)

Cover

v3.19.3.a.u2
Cover - shares
9 Months Ended
Sep. 30, 2019
Dec. 20, 2019
Cover [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Sep. 30, 2019  
Document Fiscal Period Focus Q3  
Document Fiscal Year Focus 2019  
Current Fiscal Year End Date --12-31  
Entity File Number 001-39126  
Entity Registrant Name CNS Pharmaceuticals, Inc.  
Entity Central Index Key 0001729427  
Entity Incorporation, State or Country Code NV  
Entity Current Reporting Status No  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company true  
Elected Not To Use the Extended Transition Period false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   16,450,234